Precipio Inc

Precipio Inc Stock Forecast & Price Prediction

Live Precipio Inc Stock (PRPO) Price
$6.25

1

Ratings

  • Buy 1
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$6.25

P/E Ratio

-1.38

Volume Traded Today

$14,700

Dividend

Dividends not available for PRPO

52 Week High/low

8.99/4.31

Precipio Inc Market Cap

$9.2M

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $PRPO ๐Ÿ›‘

Before you buy PRPO you'll want to see this list of ten stocks that have huge potential. Want to see if PRPO made the cut? Enter your email below

PRPO Summary

The Precipio Inc (PRPO) share price is expected to decrease by 100% over the next year. This is based on calculating the average 12-month share price estimate provided by 1 stock analysts who have covered PRPO. Price targets range from $ at the low end to $ at the high end. The current analyst consensus for PRPO is a buy. Please note analyst price targets are not guaranteed and could be missed completely.

PRPO Analyst Ratings

About 1 Wall Street analysts have assignedPRPO 1 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Precipio Inc to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on PRPO. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

PRPO stock forecast by analyst

These are the latest 20 analyst ratings of PRPO.

Analyst/Firm

Rating

Price Target

Change

Date


Maxim Group

Buy


Initiates

Nov 25, 2020

Maxim Group

Buy


Initiates

Nov 22, 2019

PRPO Company Information

  • Company Name: Precipio, Inc.
  • Industry: Healthcare solutions
  • Location: New Haven, Connecticut
  • Core Services: Diagnostic products, reagents, and blood cancer testing services
  • Key Products:
    • IV-Cell: Proprietary cell culture media for hematopoietic cell lineages
    • HemeScreen: Genetic diagnostic panels for blood cancers
  • Additional Services: Biomarker testing and clinical project services for bio-pharma customers
PRPO
Precipio Inc (PRPO)

When did it IPO

N/A

Staff Count

51

Country

United States

Sector/Industry

Healthcare/Diagnostics & Research

CEO

Mr. Ilan Danieli

Market Cap

$9.2M

Precipio Inc (PRPO) Financial Data

In 2023, PRPO generated $15.2M in revenue, which was a increase of 61.46% from the previous year. This can be seen as a signal that PRPO's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$6.1M

Revenue From 2021

$8.8M

45.26 %
From Previous Year

Revenue From 2022

$9.4M

6.36 %
From Previous Year

Revenue From 2023

$15.2M

61.46 %
From Previous Year
  • Revenue TTM $16.7M
  • Operating Margin TTM -27.2%
  • Gross profit TTM $6.0M
  • Return on assets TTM -19.0%
  • Return on equity TTM -29.2%
  • Profit Margin -22.9%
  • Book Value Per Share 8.24%
  • Market capitalisation $9.2M
  • Revenue for 2021 $8.8M
  • Revenue for 2022 $9.4M
  • Revenue for 2023 $15.2M
  • EPS this year (TTM) $-2.29

Precipio Inc (PRPO) Latest News

No news data available.

...

PRPO Frequently asked questions

The highest forecasted price for PRPO is $ from at Maxim Group.

The lowest forecasted price for PRPO is $ from from Maxim Group

The PRPO analyst ratings consensus are 1 buy ratings, 0 hold ratings, and 0 sell ratings.